[ad_1]
Featured news from Health
The Minister of Health, Fernando Ruíz, in an interview with the magazine Dinero, assured that they already have a database to start with the vaccination that will be divided into five phases. The information was provided by the EPS and IPS.
The Minister of Health, Fernando Ruíz, announced that through the Mi Vacuna application, Colombians will be able to know their turn to acquire the vaccine against COVID-19. In addition, the portfolio manager explained, the app will work on a web page. (Read: Colombia will begin mass vaccination against the coronavirus in February 2021)
In an interview with Dinero magazine, Ruíz explained that “the tool already has databases and thus the nominal lists of those who will be vaccinated in the first phases can be consulted.” The information, added Ruíz, was provided by the EPS and IPS of the country, which will also have the task of reporting all the diagnoses of their patients to update the waiting line for the vaccine.
According to Ruíz, the application will also allow Colombians to support and argue why they could receive the vaccine as a priority. And the request would be studied by the entity. In addition, Ruíz explained, constant controls and audits will be carried out on the application of the vaccine. (You can read: These would be the conditions in Colombia for the emergency use of COVID-19 vaccines)
This will be the vaccination phase in Colombia
The vaccination will have five stages. In the first Health workers and front-line assistants will be vaccinated. Also those over 80 years old for having the highest risk. The second stage It will be focused on those over 60 and second-line health workers. The third stage would correspond to people between 16 and under 60 with comorbidities. At this stage, 100% of the basic education teachers will be included. Fourth stage they would be institutional caregivers and people of different risks. The Fifth stage it would be the rest of the population.
Colombia closed a first agreement with Pfizer to acquire 10 million doses of the vaccine manufactured using messenger RNA technology that has already been approved in Europe and the United States. President Duque also announced another deal closed with the AstraZeneca-Oxford laboratory for 10 million doses. (Also read: “Ensuring equitable access to the vaccine will be the next challenge”)
In addition, the government negotiated another 20 million doses that were purchased through a joint negotiation mechanism with other countries known as Covax. And, recently, it reached an agreement with Janssen to purchase 9 million vaccines.
